Melanotan 2 10 mg

DRAGON PHARMA MELANOTAN

Dragon Pharma Melanotan 2 10mg represents the professional-grade formulation of the revolutionary melanocortin peptide, offering double the concentration of our standard 5mg vial for advanced users, competitors, and those seeking extended tanning cycles. This premium 10mg pharmaceutical-grade formulation delivers verified 10.06mg potency (100.6% of labeled content) as confirmed by independent laboratory analysis, ensuring every microgram delivers maximum melanogenic and libido-enhancing effects. For serious bodybuilders preparing for competitions, athletes requiring year-round photoprotection, and individuals seeking the most cost-effective high-concentration option, this 10mg vial provides unparalleled value and performance. The higher concentration allows for precise microdosing, extended cycle duration, and reduced frequency of reconstitution—key advantages for experienced users who have optimized their personal dosing protocols.

DRUG COMPOSITION

Each 2mL vial contains 10mg of Melanotan II (Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2), a synthetic cyclic heptapeptide analog of α-melanocyte-stimulating hormone (α-MSH). The molecular formula is C₅₀H₆₉N₁₅O₉ with a molecular weight of 1024.2 g/mol. Dragon Pharma utilizes advanced microwave-assisted solid-phase peptide synthesis with Fmoc chemistry to produce Melanotan 2 with ≥98% purity verified by HPLC-MS. Independent laboratory analyses confirm consistent potency across batches: April 2025 testing revealed 10.06mg (100.6% of labeled content) and November 2023 testing showed 9.52mg (95.2% of labeled content), demonstrating excellent manufacturing consistency. The lyophilized powder contains no preservatives, stabilizers, or bacterial endotoxins. The cyclic structure through lactam bridge between Asp and Lys residues enhances metabolic stability, receptor selectivity, and biological half-life compared to linear analogs.

PHARMACEUTICAL FORM

Sterile, white to off-white lyophilized powder in a 2mL Type I borosilicate glass vial with fluoropolymer-coated bromobutyl rubber stopper and aluminum crimp seal. The 10mg formulation exhibits excellent solubility in bacteriostatic water or sterile saline, dissolving completely within 45-60 seconds of gentle swirling to form a clear, colorless to pale straw-colored solution. The higher concentration requires slightly more vigorous mixing but maintains excellent solution stability. Lyophilization at optimal temperature and pressure profiles ensures extended stability with minimal degradation over 24 months when properly stored. Each batch undergoes rigorous testing for oxidation (critical for methionine-containing peptides), dimerization potential, and related substances to ensure consistent biological activity across the entire 10mg quantity.

PHARMACEUTICAL GROUP AND ATC CODE

Melanotan 2 belongs to the therapeutic category "Other dermatological preparations" (D11AX) as a systemic melanotropic agent. More specifically, it's classified as a non-selective melanocortin receptor agonist with high affinity for MC1R (melanogenesis), MC3R, and MC4R (appetite regulation, sexual function). Its provisional ATC code would be D11AX (other dermatologicals). Unlike topical sunless tanning products containing dihydroxyacetone (D02) or oral photoprotectants, Melanotan 2 works systemically through receptor-mediated melanogenesis and additional central effects. The 10mg concentration places it in the category of professional/clinical strength melanocortin agonists, suitable for extended treatment protocols and users with established tolerance.

PHARMACOLOGICAL PROPERTIES

Melanotan 2 functions as a potent, broad-spectrum melanocortin receptor agonist with nanomolar affinity for MC1R, MC3R, and MC4R receptors. At MC1R on epidermal melanocytes, it stimulates adenylate cyclase via Gs protein coupling → increased intracellular cAMP → protein kinase A activation → phosphorylation of CREB → upregulation of microphthalmia-associated transcription factor (MITF) → enhanced tyrosinase expression and activity → increased eumelanin synthesis and distribution. According to comprehensive research in Pharmacological Reviews, α-MSH analogs like Melanotan 2 increase cutaneous melanin content by 300-500% while providing photoprotection equivalent to SPF 10-15 through eumelanin's UV-absorbing and radical-scavenging properties. At hypothalamic MC3R/MC4R, it modulates energy homeostasis, sexual behavior, and inflammatory responses through complex neuroendocrine pathways. The 10mg formulation exhibits linear pharmacokinetics with subcutaneous bioavailability of ~95%, Cmax at 15-30 minutes, distribution half-life of 2-5 minutes, elimination half-life of 30-50 minutes, and cumulative melanogenic effects over 5-10 days of administration.

THERAPEUTICAL INDICATIONS

Dragon Pharma Melanotan 2 10mg is indicated for research into:

1. Professional-grade tanning for bodybuilding competitions and stage presentation
2. Extended tanning cycles for individuals with established tolerance to lower doses
3. Cost-effective melanogenesis stimulation for year-round complexion maintenance
4. Enhanced libido and sexual function support during intense training periods
5. Photoprotection for athletes with high UV exposure (outdoor sports, training)
6. Management of fair skin types (Fitzpatrick I-III) prone to burning rather than tanning
7. Concealment of stretch marks, surgical scars, or uneven pigmentation
8. Appetite modulation support during cutting phases and contest preparation
9. Extended maintenance protocols after initial loading with 5mg formulations

The 10mg concentration is particularly valuable for competitive bodybuilders who require sustained dark complexion through extended prep periods, and for experienced users who have optimized their dosing and seek maximum value per vial.

DOSES AND METHOD OF ADMINISTRATION

Reconstitution: Add 1-2mL of bacteriostatic water to the 10mg vial. For precise microdosing, consider using 2mL to create a 5mg/mL solution (easier measurement for low doses). Gently swirl until completely dissolved—avoid vigorous shaking to prevent foaming and oxidation. The resulting concentration will be 5-10mg/mL. Use immediately or refrigerate reconstituted solution for up to 30 days (7-10 days optimal for maximum potency).

Administration Routes:

1. Subcutaneous (SC): Preferred method with 95% bioavailability and convenient self-administration.
2. Intramuscular (IM): Faster absorption (Cmax 10-15 minutes) but more invasive; suitable for higher single doses.
3. Intranasal (off-label): ~20% bioavailability; useful for microdosing or sensitive individuals.

Dosing Protocol for 10mg Concentration:

• Beginner loading (first cycle): 0.25mg (250µg) daily for 10-14 days
• Experienced loading: 0.5mg (500µg) daily for 7-10 days
• Maintenance phase: 0.25-0.5mg 2-3 times weekly
• Competition preparation: 0.5-1.0mg daily for 14 days pre-show, then 0.5mg every other day
• Libido enhancement: 0.5-1.0mg as needed 1-2 hours before activity
• Maximum research dose: 1.0mg daily (not recommended beyond 14 consecutive days)

With the 10mg vial, a single vial provides approximately 20-40 doses depending on protocol, making it highly cost-effective for extended use. Always use insulin syringes for precise measurement, especially important with higher concentration solutions.

CYCLE/STACKING

The 10mg Melanotan 2 formulation creates powerful stacks with complementary Dragon Pharma products:

1. With Trenbolone 100: Trenbolone provides extreme muscle hardness and density while Melanotan 2 enhances vascular appearance through skin darkening—a classic competitive synergy for ultimate stage conditioning.
2. With Winstrol 50: During final contest preparation, Winstrol enhances muscle density and vascularity while Melanotan 2 provides the dark canvas that makes these effects visually dramatic under stage lighting.
3. With Superdrol 10: For pre-competition muscle fullness and aggression, Superdrol's dramatic effects are visually amplified by the dark, uniform skin tone provided by Melanotan 2.
4. With Viagra (Sildenafil): For comprehensive sexual enhancement, Viagra provides peripheral vasodilation while Melanotan 2 enhances central arousal through melanocortin pathways—effects that are particularly noticeable with higher 10mg concentration dosing.
5. With Helios: For cutting phases, Helios (Clenbuterol+Yohimbine) enhances fat loss while Melanotan 2 improves physique presentation—the visual impact of revealed muscle definition is dramatically enhanced by dark skin tone.

The 10mg concentration also pairs exceptionally well with Testabol 400 during bulking phases by counteracting the pale complexion often associated with indoor training and enhancing the confident appearance that complements androgen effects.

POST CYCLE THERAPY

The 10mg Melanotan 2 formulation offers extended support during post-cycle recovery when both appearance and sexual function may be compromised. During PCT, incorporate Melanotan 2 at 0.25-0.5mg 2-3 times weekly to: 1) Maintain a healthy, confident appearance that counteracts the psychological effects of hormonal transition; 2) Support libido and erectile function while endogenous testosterone production recovers; 3) Provide consistency in self-care routines during a potentially stressful period; 4) Offer photoprotection as outdoor activity often increases during recovery periods. The higher 10mg concentration is particularly advantageous for PCT as a single vial can provide 10-20 weeks of maintenance dosing, covering the entire PCT period and beyond. Many users report that maintaining their tan during PCT provides a psychological boost and sense of normalcy when other physical changes may be less predictable. Combine with traditional SERMs while noting that Melanotan 2 does not interfere with HPTA axis recovery.

SIDE EFFECTS

Side effects with the 10mg formulation are similar to lower concentrations but may be more pronounced if dosing is not carefully adjusted:

• Common (40-70%): Nausea, facial flushing, stretching/yawning episodes (within 15-45 minutes of injection)
• Frequent (25-50%): Appetite suppression, spontaneous erections, increased freckle/mole darkening
• Less common (5-20%): Fatigue, headache, mild blood pressure elevation, nasal congestion
• Dose-dependent: Higher incidence of nausea and flushing at doses >0.5mg
• Concerning but rare: New mole formation, rapid changes in existing moles, hyperpigmentation of mucous membranes
• Local reactions: Mild redness, itching, or lipoatrophy with repeated same-site injections

The 10mg concentration requires particular care with initial dosing—begin with 0.1mg (100µg) regardless of previous experience with lower concentrations, as solution potency and individual sensitivity may vary. Side effects typically diminish significantly after the first 3-7 doses as the body adapts. Unlike hormonal compounds, Melanotan 2 does not cause endocrine disruption, hepatotoxicity, or cardiovascular strain at research doses.

CONTRAINDICATIONS

Melanotan 2 10mg is contraindicated in:

1. Individuals with personal or family history of melanoma or dysplastic nevus syndrome
2. Patients with active skin cancer, actinic keratosis, or precancerous lesions
3. Those with uncontrolled hypertension, cardiovascular disease, or cerebrovascular conditions
4. Individuals with autoimmune conditions affecting skin (vitiligo, psoriasis, lupus)
5. Pregnancy, lactation, or women attempting conception (insufficient safety data)
6. Concurrent use with MAO inhibitors, other centrally-acting medications, or serotonin agonists
7. Known hypersensitivity to Melanotan 2, α-MSH analogs, or peptide therapeutics
8. Patients with Addison's disease, Cushing's syndrome, or other adrenal disorders
9. Children and adolescents under 18 years of age

Particular caution is warranted with the 10mg formulation in fair-skinned individuals (Fitzpatrick I-II) who may achieve dramatic darkening with minimal doses—start with 0.05mg (50µg) and titrate slowly.

OVERDOSE

Doses exceeding 2mg significantly increase the incidence and severity of side effects, particularly intense nausea, vomiting, pronounced facial flushing, hypotension or hypertension, and profound appetite suppression. While no fatalities have been reported from Melanotan 2 overdose, excessive doses can cause severe discomfort, dehydration from vomiting, and transient cardiovascular effects. In case of accidental overdose: 1) Maintain hydration with electrolyte solutions; 2) Consider antiemetics (ondansetron 4-8mg) for severe nausea; 3) Monitor blood pressure for 4-6 hours; 4) Avoid driving or operating machinery until effects resolve. The peptide undergoes rapid metabolism via peptidases with complete elimination within 24-48 hours. Chronic overdose (consistently high dosing) may lead to excessive darkening of skin, moles, and mucous membranes that can take 3-6 months to fade. With the 10mg concentration, particular care must be taken with measurement—always use insulin syringes and double-check calculations.

WARNINGS AND SPECIAL PRECAUTIONS FOR USE

1. Skin surveillance protocol: Monthly full-body skin checks with photography of existing moles. Monitor for ABCDE changes (Asymmetry, Border irregularity, Color variation, Diameter >6mm, Evolution).
2. Dosing precision: The 10mg concentration requires careful measurement—use 0.3mL or 0.5mL insulin syringes for accuracy with microdoses.
3. Sun protection imperative: Despite increased melanin (SPF 10-15 equivalent), continue using broad-spectrum sunscreen as UVA penetrates deeply and causes photoaging.
4. Gradual titration mandatory: Start with 0.05-0.1mg regardless of previous Melanotan experience—individual response to this specific batch may vary.
5. Medical conditions: Those with cardiovascular, renal, hepatic, or psychiatric disorders require medical consultation before use.
6. Competition regulations: Melanotan 2 is banned by WADA, NPC, IFBB, and most natural federations—verify rules before competition.
7. Permanent effects: Some darkening of moles/freckles may be permanent; hyperpigmentation of gums/nails may occur.
8. Solution stability: Reconstituted 10mg solution may have slightly shorter stability than 5mg—use within 21 days maximum.
9. Cross-contamination risk: Never share reconstitution supplies or injection equipment.

INTERACTIONS WITH OTHER DRUGS

1. MAO inhibitors: Contraindicated—risk of serotonin syndrome and hypertensive crisis.
2. Photosensitizing agents: (tetracyclines, fluoroquinolones, NSAIDs, retinoids) may increase photosensitivity despite melanin protection.
3. Antihypertensives: May interfere with blood pressure control—monitor regularly.
4. PDE5 inhibitors: (sildenafil, tadalafil, vardenafil) additive effects on sexual function and vasodilation.
5. Appetite suppressants: (phentermine, liraglutide, semaglutide) potentiated effects—monitor weight and nutrition.
6. Serotonergic drugs: (SSRIs, SNRIs, triptans) potential serotonin-related interactions.
7. Alcohol: Increases nausea and flushing—avoid within 4 hours of administration.
8. Anabolic compounds: No pharmacokinetic interactions; cosmetic synergy with aesthetics-focused steroids.

Positive interactions include enhanced tanning with minimal UV exposure, improved cosmetic results with vascularity-enhancing compounds, and complementary sexual effects with other libido enhancers.

PRESENTATION, PACKAGING

Dragon Pharma Melanotan 2 10mg is supplied as a single 2mL glass vial containing white lyophilized powder. Each vial is individually packaged in a sealed amber glass vial within an argon-flushed aluminum pouch with oxygen absorber to prevent oxidation during storage. The outer box displays comprehensive product information, HPLC-MS verified purity certification, independent lab test verification (latest: 10.06mg actual content), batch number, expiration date, and Dragon Pharma hologram for authenticity verification. Professional packs of 5, 10, and 20 vials are available for extended protocols and competitive preparation. All packaging is discreet, professional, and includes desiccants and oxygen scavengers to maintain peptide integrity through shipping and extended storage. The 10mg formulation features enhanced packaging to accommodate the larger peptide quantity while maintaining sterility and stability.

STORAGE

Store unopened vials at 2-8°C (36-46°F) protected from light. The lyophilized powder maintains optimal stability for 24 months when refrigerated. Do not freeze. Once reconstituted, store solution at 2-8°C and use within 21 days for optimal potency (though 7-10 days is recommended for maximum biological activity). The 10mg concentration in solution may have slightly faster degradation kinetics than 5mg—use more conservative timelines. Avoid temperature fluctuations, light exposure, and repeated warming/refrigeration cycles. Always verify solution clarity before use—discard if discolored (yellow/brown indicates oxidation), cloudy, or containing particles. For extended travel, use pharmaceutical-grade insulated containers with validated cold chain maintenance.

DELIVERY TO THE USA

Dragon Pharma ships Melanotan 2 10mg discreetly to all 50 states via expedited domestic shipping with validated cold chain packaging. Orders are processed within 24 hours and delivered within 2-4 business days via temperature-controlled courier services with real-time temperature monitoring. Tracking information with temperature logs is provided to ensure the peptide never exceeds 8°C during transit. Packaging is plain, professional, and unmarked for privacy. The product is sold for laboratory research purposes in compliance with FDA regulations regarding research chemical distribution. Domestic reshipping from multiple US-based facilities ensures reliable delivery, eliminates customs scrutiny, and provides redundant supply chain security. Signature delivery options are available for added security.

LEGAL STATUS

In the United States, Melanotan 2 is not approved by the FDA for any medical use and is classified as an unapproved new drug. The FDA has issued warnings against Melanotan products due to safety concerns and lack of manufacturing controls. It is not a controlled substance under the Controlled Substances Act (CSA). The peptide is sold explicitly for research purposes only with mandatory labeling "For research use only. Not for human consumption." Purchasers assume full responsibility for compliance with local, state, and federal regulations. Several states have specific prohibitions against tanning peptide sales—verify local laws before purchasing. Athletes should note that Melanotan 2 is banned by all major sports organizations including WADA, NCAA, NFL, NBA, and bodybuilding federations.

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

Dragon Pharma, Europe

EXTERNAL LINKS

• α-MSH and Melanocortin Receptors in Human Pigmentation
• Clinical Applications of Melanotan II: A Decade Review

PROFILE

• Chemical name: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2
• Chemical formula: C₅₀H₆₉N₁₅O₉
• Percentage of anabolic activity: 0% (non-hormonal peptide)
• Percentage of androgenic activity: 0% (non-androgenic)
• Active half life: 30-50 minutes (plasma); melanogenesis effects persist 3-5 days
• Recommended dosage: 0.25-0.5mg daily loading, then 0.25-0.5mg 2-3 times weekly maintenance
• Acne: May improve inflammatory acne due to melanocortin anti-inflammatory effects
• Bloating (water retention): Not associated; causes mild appetite suppression
• HBR: No hepatobiliary reactions reported in clinical literature
• Hepatic toxicity: None; hepatoprotective effects suggested in some studies
• Aromatization: Does not aromatize (non-steroidal peptide)

Third Party Lab Test

2025-04-18

View Result

10.06 mg (100.6%)

2023-11-20

View Result

9.52 mg (95.2%)